 PORTLAND, Maine, Sept. 14, 2022 GLOBE NEWSWIRE -- ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, announced today it will participate in the Lytham Partners Fall 2022 Investor Conference taking place virtually on September 28-29, 2022. 